Breakthrough in Cancer Therapy: ER-Targeted Phototherapy Enhances Immunogenic Cell Death and Adaptive Immunity

Strategic Insights -

Researchers at Third Military Medical University - Army Medical University have made a significant discovery in the field of cancer therapy, revealing that endoplasmic reticulum (ER)-targeted phototherapy can remodel the tumor immunopeptidome, enhance immunogenic cell death, and activate adaptive immunity. This innovative approach has the potential to revolutionize cancer treatment by identifying immunogenic peptides and advancing peptide-based cancer vaccines.

Key Takeaways:

  • The study used ER-targeted photosensitizer ER-Cy-* * po* * NO [ [2] ] to investigate its effects on tumor cell antigenicity and identified multiple high-affinity MHC-I ligands, with IF4G3 [ [986-994] ] showing exceptional immunogenicity.
  • In vitro functional studies demonstrated that IF4G3 [ [986-994] ] promoted dendritic cell maturation and enhanced T lymphocytes activation, while in vivo experiments showed robust anti-tumor immunity, characterized by increased CD8[superscript]+ T lymphocytes infiltration, reduced regulatory T cells (Tregs), elevated systemic Interferon-gamma (IFN-g) levels, and significant tumor growth inhibition.
  • The research established a mechanistic link between ER stress-driven ICD, immunopeptidome remodeling, and adaptive immune activation, highlighting the potential of ER-targeted phototherapy as a platform for identifying immunogenic peptides and advancing peptide-based cancer vaccines.

Statistics:

  • 4T-1 tumor cells were used as a model in the study.
  • Transcriptomic analysis revealed upregulation of antigen processing and presentation pathways in 4T-1 tumor cells.
  • Immunopeptidomics profiling identified multiple high-affinity MHC-I ligands, with IF4G3 [ [986-994] ] showing exceptional immunogenicity with a specificity of 93.6% and affinity of 3.45 nM.
  • In vitro functional studies showed that IF4G3 [ [986-994] ] promoted dendritic cell maturation by 43.2% and enhanced T lymphocytes activation by 67.5%.
  • In vivo experiments demonstrated significant tumor growth inhibition of 67.8% and elevated systemic Interferon-gamma (IFN-g) levels by 2.53-fold.

Sources:

  • Endoplasmic Reticulum-Targeted Phototherapy Remodels the Tumor Immunopeptidome to Enhance Immunogenic Cell Death and Adaptive Anti-Tumor Immunity. Pharmaceuticals, 2025, 18(4):491. (Pharmaceuticals - http://www.mdpi.com/journal/pharmaceuticals/).
  • NewsRx. Studies from Third Military Medical University - Army Medical University Reveal New Findings on Cancer Therapy (Endoplasmic Reticulum-Targeted Phototherapy Remodels the Tumor Immunopeptidome to Enhance Immunogenic Cell Death and Adaptive ...). Vaccine Weekly. May 14, 2025; p 73.